Le Lézard
Classified in: Health
Subjects: PDT, FDA

Preparation products of Yiling Pharma approved by FDA for launch in the US market


SHIJIAZHUANG, China, Sept. 19, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd. announced on Friday that it had received the approvals of the Abbreviated New Drug Applications (ANDA) about Lisinopril Tablets and Acyclovir Capsules, from United States Food and Drug Administration (hereinafter referred to as the "FDA"), which were submitted by Yiling Wanzhou International Pharmaceutical Co., Ltd., one of the wholly-owned subsidiaries of Yiling Pharmaceutical Co., Ltd., meaning that these products are approved to be produced and sold in the U.S. market.

The announcement showed that Lisinopril Tablets are mainly used for the treatment of essential hypertension (EH) and renal vascular hypertension (RVH) and were originally researched and developed by Astrazeneca and approved for launch in the United States in 1988. Currently its licensed producer is Alvogen Malta Operations Ltd., and the major manufacturers of its generic drugs are Casi, Ascent, and etc. in the United States. In addition to the originally researched and developed drugs, there are 11 producers for the generic drugs in China, among which, only one has passed the consistency evaluation. According to the IMS database, the saleroom of Lisinopril Tablets was about USD 131.39 million in the U.S. market in 2019.

Mainly used to treat herpesvirus infection, Acylovir Capsules was launched in the U.S. market in 1985. It was researched and developed by GlaxosmithKline. At present, its licensed producer is Mylan Company and the major manufacturers of its generic drugs are Apotex, Teva and etc. in the United States. There are no varieties that have passed the consistency evaluation in China yet. According to the IMS database, the saleroom of Acylovir oral preparations was about USD 180.48 million in the U.S. market in 2019.

Up to now, Yiling has invested about USD 2.77 million and USD 1.84 million in the R&D projects of Lisinopril Tablets and Acyclovir Capsules, respectively.

Yiling Pharmaceutical indicated that the approvals of Lisinopril Tablets and Acyclovir Capsules obtained from FDA marked that Yiling Wanzhou International Pharmaceutical Co., Ltd. has qualified for selling the products above in the U.S. market and such products are expected to bring new profit growth points for the company after their launch in the U.S. market. The company will actively promote the preparation for their launch in the U.S. market.

SOURCE Shijiazhuang Yiling Pharmaceutical Co, Ltd.


These press releases may also interest you

at 12:46
Olympus, a leading global medtech company providing innovative solutions for medical and surgical procedures, announced today a milestone for its iTindtm device with its availability and greater patient access through the largest healthcare group...

at 12:46
Amid the demands of dentistry, where resilience is paramount, practitioners confront challenges beyond clinical skills alone. Thriving in this environment requires a particular mindset, enabling professionals to adeptly navigate pressures, maintain...

at 12:45
The "Global Smart Insulin Pens Market" report has been added to ResearchAndMarkets.com's offering. The global smart insulin pens market accounted for USD 0.769 billion in 2023 and is expected to reach at USD 2.30 billion by 2034 with a CAGR of...

at 12:35
MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of patients suffering from debilitating CNS...

at 12:27
This year marks the 14th anniversary of the enactment of the Affordable Care Act (ACA). Its passage was the most significant advancement of health policy since the establishment of Medicare and Medicaid in the 1960s and made healthcare accessible and...

at 12:15
ResBiotic Nutrition, Inc. (ResBiotic), the pioneering physician-developed pre/probiotic wellness scale-up, proudly announces the appointments of Stefany Nieto as Vice President of Operations and Brittany Zenner as Director of Marketing. Nieto is a...



News published on and distributed by: